Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
However, associations between APOE e2e2 genotypes and coagulation factor 11 (F11, p = 1.48E‐2), vitamin D binding protein (GC, p = 2.64E‐2) were inconsistent (Figure S1, Supporting Information).
Source: Olink Technology Validates Some of the Mass Spectrometry‐Based Analysis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E
Study design awaiting verification · Advanced Science · 2025
Original publication title
A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E
© 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
A signature of 16 serum proteins that were previously profiled using the aptamer‐based Somascan technology highlighted the roles of the e2 allele of APOE in lipid regulation via apolipoprotein B (APOB) and apolipoprotein E (APOE) and in inflammation. Here, the serum protein signature of APOE is validated and expanded using a combination of mass‐spectrometry, ELISA, Luminex, blood transcriptomics, and antibody‐based Olink serum proteomics. Some of the findings were replicated in the UK Biobank using antibody‐based Olink serum proteomics. This analysis replicated the association between APOB and the e2 allele of APOE, detected a new, robust pattern of association between APOE genotypes and the serum level of APOE, and discovered new associations between APOE genotypes and the complex of apolipoproteins APOC1, APOC2, APOC3, APOC4, APOE, APOF, and APOL1.
In addition, 13 new proteins correlated with APOE genotypes. This extended signature includes granule proteins CAMP, CTSG, DEFA3, and MPO secreted from neutrophils and points to olfactomedin 4 (OLFM4) as a new target for the prevention of Alzheimer's disease.
Authors’ abstract
Abstract
A signature of 16 serum proteins that were previously profiled using the aptamer‐based Somascan technology highlighted the roles of the e2 allele of APOE in lipid regulation via apolipoprotein B (APOB) and apolipoprotein E (APOE) and in inflammation. Here, the serum protein signature of APOE is validated and expanded using a combination of mass‐spectrometry, ELISA, Luminex, blood transcriptomics, and antibody‐based Olink serum proteomics. Some of the findings were replicated in the UK Biobank using antibody‐based Olink serum proteomics. This analysis replicated the association between APOB and the e2 allele of APOE, detected a new, robust pattern of association between APOE genotypes and the serum level of APOE, and discovered new associations between APOE genotypes and the complex of apolipoproteins APOC1, APOC2, APOC3, APOC4, APOE, APOF, and APOL1.
In addition, 13 new proteins correlated with APOE genotypes. This extended signature includes granule proteins CAMP, CTSG, DEFA3, and MPO secreted from neutrophils and points to olfactomedin 4 (OLFM4) as a new target for the prevention of Alzheimer's disease.
Publication and source details
Original title: A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E
Paola Sebastiani; Eric Reed; Kevin B Chandler; Prisma Lopez; Hannah Lords; Harold Bae; Catherine E Costello; Matthew Au; Lingyi Lynn Deng; Mengze Li; Qingyan Xiang; Heeju Noh; Lance Pflieger; Cory Funk; Noa Rappaport; Marianne Nygaard; Meghan I Short; Michael Brent; Stefano Monti; Stacy L Andersen; Thomas T Perls
Advanced Science · 2025
* E‐mail: paola.sebastiani@tuftsmedicine.org© 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbHhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. National Institutes of Health, NIA U19‐AG023122U19‐AG063893UH2‐AG064704R24‐GM134210S10‐OD021728R01‐AG061844
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:29:33.513342+00:00
DOI: 10.1002/advs.202509764 · PMC12822458